Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy.
about
Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Treatment patterns, overall su ...... bitors as second-line therapy.
@en
type
label
Treatment patterns, overall su ...... bitors as second-line therapy.
@en
prefLabel
Treatment patterns, overall su ...... bitors as second-line therapy.
@en
P2093
P1476
Treatment patterns, overall su ...... bitors as second-line therapy.
@en
P2093
B Douglas Smith
Daniel Fernandez
Dominick Latremouille-Viau
P304
P356
10.1185/03007995.2016.1140030
P407
P50
P577
2016-01-08T00:00:00Z